CIRCULATING ACE2 ACTIVITY IS ELEVATED IN SEVERE COVID-19

https://storage.unitedwebnetwork.com/files/1099/7f595d2d80c56291930ab446aaf35c0c.pdf

Irene Martínez-Díaz irene.martinez.diaz@vhir.org Vall d'Hebron Research Institute Nephrology and Transplantation Research Group Barcelona

Ander Vergara vergara.ander@gmail.com Vall d'Hebron Research Institute Nephrology and Transplantation Research Group Barcelona

José Tomas Ortiz JTORTIZ@clinic.cat Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) Department of Cardiology Barcelona

Antonio Cano Camara acanocam8@alumnes.ub.edu Vall d'Hebron Institute Research Nephrology and Transplantation Research Group Barcelona

Adrià Fernández Díaz AFERNANDEZD@recerca.clinic.cat Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) Department of Cardiology Barcelona

Carmen Llorens-Cebrià carmen.llorens@vhir.org Vall d'Hebron Institute Research Nephrology and Transplantation Research Group Barcelona

Pablo García de Frutos pablo.garcia@iibb.csic.es Instituto de Investigaciones Biomédicas de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC) Cell Death and Proliferation Barcelona

Albert Morales albert.morales@iibb.csic.es Instituto de Investigaciones Biomédicas de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC) Cell Death and Proliferation Barcelona

Conxita Jacobs-Cachá conxita.jacobs@vhir.org Vall d'Hebron Institute Research Nephrology and Transplantation Research Group Barcelona

Maria José Soler mariajose.soler@vallhebron.cat Vall d'Hebron Institute Research Nephrology and Transplantation Research Group Barcelona